Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Nov 20, 2019
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
Overview of Procedures: The PACE-Life Group will be integrated into the Schizophrenia Treatment and Evaluation Program (STEP) outpatient clinics in Raleigh, NC and Carrboro, NC. The group walks will occur on a secure online platform (Zoom). Goal-setting groups and all assessments will also take place on a secure online platform (Zoom). Goal-setting will include setting goals for the upcoming week in terms of number of steps as well as how many intensity walks individuals plan to complete. Clinic-based group sessions will also include if-then plans and problem solving any issues that interfe...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • DSM-V diagnosis of a SSD (Schizophrenia, Schizoaffective Disorder, Brief Psychotic Disorder, Schizophreniform Disorder, and Unspecified Schizophrenia Spectrum and Other Psychotic Disorder)
- • Between the ages of 18-65, both genders, and any ancestry
- • Reading level \> 4th grade. Reading level will be measured by WRAT.
- • No hospitalizations for psychiatric reasons in the last 3 months
- • Clinically stable (no psychiatric medication changes within the past month)
- • Are not already engaging in consistent moderate-intensity exercise (cutoff = 60 min/week for the past 6 months)
- • Present with no contra-indication to engage in regular moderate intensity exercise based on the American College of Sports Medicine guidelines
- • Willing and able to provide informed consent or has legal guardian present to provide informed consent.
- Exclusion Criteria:
- • Pregnant women will be excluded because pregnancy alters autonomic and immune responsiveness, increase weight gain, and can influence heart rate
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Raleigh, North Carolina, United States
Patients applied
Trial Officials
David L Penn, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials